期刊文献+

医院获得性假丝酵母菌菌血症的临床回顾性分析

Nosocomial candidemia:clinical retrospective analysis
原文传递
导出
摘要 目的分析假丝酵母菌菌血症的高危因素、临床表现、菌群分布和临床诊治。方法对2008年3月-2010年5月血培养确诊为假丝酵母菌菌血症的19例患者临床资料进行回顾分析。结果 84.2%的假丝酵母菌菌血症患者有≥3种基础疾病,100.0%患者有≥4个高危因素,94.7%患者有静脉导管留置,63.2%患者为导管相关性感染;以发热、白细胞和中性粒细胞升高、各脏器功能不全为主要表现,白色假丝酵母菌、光滑假丝酵母菌、热带假丝酵母菌、近平滑假丝酵母菌、克柔假丝酵母菌分别占47.4%、15.8%、15.8%、15.8%、5.2%,治疗措施包括拔除深静脉导管和给予抗真菌药物,治愈率为63.2%。结论假丝酵母菌菌血症多发生于有多个基础疾病和多个高危因素者,以白色假丝酵母菌较为多见。 OBJECTIVE To analyze the risk factors, clinical manifestation and flora distribution of candidemia and provide a reference for clinical diagnosis and therapy. METHODS Totally 19 cases of candidemia in our hospital were analyzed retrospectively from Mar 2008 to May 2010. RESULTS 84.2% of patients with candidemia suffered from three or more, underlying diseases. All of the patients with candidemia had four or more high risk factors. 94.7% of patients with candidemia were placed catheter and 63.2% of patients with candidemia were confirmed CRBSI. Of these clinical manifestations , fever, elevated white cells and neutrophils, failure of liver, kidney and circulation and MODS were the main manifestations. The distribution of isolated Candida species were Candida albicans (47.4%), Candida glabrata (15.8%), Candida tropicalis (15.8%), Candida para psilosis (15.8%) and Candida krusei (5.2%). Therapeutic measure included removing catheters and using antifungal agents. The cure rate of patients with candidemia was 63. 2%. CONCLUSION Candidemia usually occurs in patients who suffered from multiple underlying diseases and with high risk factors, of which Candida albicans is the most common pathogen.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2011年第14期2957-2959,共3页 Chinese Journal of Nosocomiology
关键词 假丝酵母菌菌血症 高危因素 抗真菌治疗 Candidemia High risk factors Antifungal therapy
  • 相关文献

参考文献11

  • 1冯文莉,杨静,张荣丽,王丽.医院内深部真菌感染的病原学及危险因素研究进展[J].中华医院感染学杂志,2008,18(5):747-750. 被引量:43
  • 2冯文莉,杨静,奚志琴,朱永乐,张润梅.3年间医院内侵袭性真菌感染的病原菌分布及临床分析[J].中华医院感染学杂志,2008,18(7):1030-1033. 被引量:45
  • 3Pfaller MA,Diekma DJ. Epidemiology of invasive candidiasis: a persistent public health problem[J]. Clin Microbiol Rev, 2007,20(1) : 133-163.
  • 4Ascioglu S,Rex JH, de Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietie stem cell transplants:an international consensus[J]. Clin Infect Dis, 2002,34 (1) : 7-14.
  • 5Mermel LA, Allon M,Bouze E,et al. Clinical practice guidelines for the diagnosis and management of intravascular cathe- ter-related infection: 2009 Update by the Infectious Diseases Society of America[J]. Clin Infect Dis, 2009,49 (1) : 1-45.
  • 6医院感染诊断标准(试行)[J].中华医学杂志,2001,81(5):314-320. 被引量:6516
  • 7唐蕾,崔颖鹏,王振宁.血液感染常见病原真菌分布及耐药性分析[J].中国热带医学,2007,7(6):973-974. 被引量:7
  • 8Horn DL, Neofytos D, Anaissie EJ,et al. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry[J]. Clin Infect Dis, 2009,48(12) : 1695-1703.
  • 9Pappas PG, Kauffman CA, Andes D, et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Disease Society of America[J]. Clin Infect Dis, 2009,48(5) : 503-535.
  • 10Morrell M, Fraser VJ,Kollef MH. Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality[J]. Antimicrob Agents Chemother, 2005,49 (9) : 3640-3645.

二级参考文献43

共引文献6601

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部